Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
“In previous research, we showed that patients treated with quizartinib had improved survival...
Read More
Author: cfelixcpa
Combination immunotherapy produces high response rate in early results of Sylvester trial targeting high-risk follicular lymphoma
“It’s a high-risk population, and we’re trying to improve outcomes for these patients,” said Dr....
Read More
CENTENE CORPORATION ANNOUNCES 2024 GUIDANCE
2024 adjusted diluted EPS of greater than $6.70. Board authorizes $4.0 billion increase to stock...
Read More
New Sylvester Cancer Study Provides Insight Into Underlying Gene Mutations in Myelodysplastic Syndromes
Findings could lead to development of more effective drug combinations to treat MDS patients...
Read More
Dr. David Swoboda Promoted to Clinical Director of Leukemia Program at TGH Cancer Institute
Dr. David Swoboda is a physician-scientist focusing on therapeutics for patients with acute...
Read MoreRecent Posts
